← Back to Conditions

Hypercalcemia

disorder
SNOMED 66931009CUI C0020437

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Treatments & Interventions

Cortisone

substance

Calcitonin

substance

EDTA

substance

Methylprednisolone acetate

substance

Pamidronate

substance

Prednisolone acetate

substance

Prednisolone sodium phosphate

substance

Prednisolone tertiary butylacetate

substance

Dexamethasone acetate

substance

Gallium nitrate

substance

Methylprednisolone

substance

Triamcinolone

substance

Triamcinolone diacetate

substance

Prednisolone

substance

Prednisone

substance

Cortisone acetate

substance

Salmon calcitonin

substance

Dexamethasone

substance

Etidronate

substance

Plicamycin

substance

Clinical Trials

7
Total Trials
1
Recruiting
3
With Results

Recent Trials

Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity

NCT03935984Phase 4Recruiting37 enrolled

Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)

NCT00823303Phase 4Completed110 enrolled

Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose

NCT00891813Phase 4Completed100 enrolled

Parathyroidectomy vs Cinacalcet in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation

NCT01178450Phase 4Completed30 enrolled

Efficacy of Cinacalcet in the Control of Primary Hyperparathyroidism

NCT02417389Phase 4Completed22 enrolled
View all 7 trials on ClinicalTrials.gov

Research Evidence

Peer-reviewed studies linked via MeSH term "Hypercalcemia" from the MEDLINE/PubMed database.

Sort:
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
[object Object], [object Object], [object Object] et al. · Cochrane Database Syst Rev · 2025
PMID: 40576086Meta-AnalysisFull text (PMC)
1,25-dihydroxyvitamin D-mediated hypercalcemia associated with solid organ malignancy: a systematic review.
[object Object], [object Object], [object Object] et al. · Minerva Endocrinol (Torino) · 2025
PMID: 34581546Meta-Analysis
CASRdb: A Publicly Accessible Comprehensive Database for Disease-Associated Calcium-Sensing Receptor Variants.
[object Object], [object Object], [object Object] · J Clin Endocrinol Metab · 2025
PMID: 39484850Meta-Analysis
Clinical characteristics and status of treatment of small-cell carcinoma of the ovary, hypercalcemic type in the Chinese population: a meta-analysis.
[object Object], [object Object], [object Object] et al. · J Gynecol Oncol · 2024
PMID: 38710530Meta-AnalysisFull text (PMC)
Lithium-associated hypercalcemia and hyperparathyroidism: A systematic review and meta-analysis.
[object Object], [object Object], [object Object] · World J Biol Psychiatry · 2024
PMID: 39192574Meta-Analysis
Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline.
[object Object], [object Object], [object Object] et al. · J Clin Endocrinol Metab · 2023
PMID: 36545746Meta-Analysis
Long-term supplementation with 3200 to 4000 IU of vitamin D daily and adverse events: a systematic review and meta-analysis of randomized controlled trials.
[object Object], [object Object], [object Object] et al. · Eur J Nutr · 2023
PMID: 36853379Meta-AnalysisFull text (PMC)
Patient and Physician Decisional Factors Regarding Hypercalcemia of Malignancy Treatment: A Novel Mixed-Methods Study.
[object Object], [object Object], [object Object] et al. · J Clin Endocrinol Metab · 2023
PMID: 36545699Meta-Analysis
Long-term Recurrence Rates After Surgery in Primary Hyperparathyroidism.
[object Object], [object Object], [object Object] et al. · J Clin Endocrinol Metab · 2023
PMID: 37279502Meta-Analysis
Efficacy of antiresorptive agents bisphosphonates and denosumab in mitigating hypercalcemia and bone loss in primary hyperparathyroidism: A systematic review and meta-analysis.
[object Object], [object Object], [object Object] et al. · Front Endocrinol (Lausanne) · 2023
PMID: 36817591Meta-AnalysisFull text (PMC)
Search all PubMed articles for Hypercalcemia

Research data from MEDLINE/PubMed

Related Conditions

Idiopathic hypercalcemia(child)
Secondary hypercalcaemia(child)
Familial hypocalciuric hypercalcaemia(child)
Hypercalcemia due to hyperthyroidism(child)
Hypercalcemia due to immobilization(child)
Drug-induced hypercalcaemia(child)
Milk alkali syndrome(child)
Humoral hypercalcemia of malignancy(child)
Hypercalcemia due to granulomatous disease(child)
Nutritional disorder due to calcium-phosphorus imbalance(child)
Hypercalcemia due to sarcoidosis(child)
Hypercalcemia associated with chronic dialysis(child)
Hypercalcaemia due to tuberculosis(child)
Hypocalciuric hypercalcemia(child)
Acquired hypocalciuric hypercalcaemia(child)
Myopathy co-occurrent and due to hypercalcemia(child)
Infantile hypercalcemia(child)
Hypercalcaemia due to chronic kidney disease(child)
Hypercalcaemia caused by thiazide and/or vitamin A(child)
Disorder of calcium metabolism(parent)

Quick Facts

SNOMED CT
66931009
UMLS CUI
C0020437
Fully Specified Name
Hypercalcemia (disorder)
Specialists
0
Diagnostic Biomarkers
0
Known Treatments
20
Clinical Trials
7
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.